PROCTER & GAMBLE HEALTH | FREDUN PHARMA | PROCTER & GAMBLE HEALTH/ FREDUN PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.8 | 27.7 | 125.4% | View Chart |
P/BV | x | 10.6 | 4.6 | 233.1% | View Chart |
Dividend Yield | % | 2.0 | 0.1 | 2,425.4% |
PROCTER & GAMBLE HEALTH FREDUN PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
FREDUN PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ FREDUN PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,428 | 375.7% | |
Low | Rs | 3,883 | 675 | 575.3% | |
Sales per share (Unadj.) | Rs | 740.7 | 606.3 | 122.2% | |
Earnings per share (Unadj.) | Rs | 138.2 | 23.9 | 579.4% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 30.1 | 516.2% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0.70 | 13,571.4% | |
Avg Dividend yield | % | 2.1 | 0.1 | 3,085.9% | |
Book value per share (Unadj.) | Rs | 447.6 | 194.4 | 230.3% | |
Shares outstanding (eoy) | m | 16.60 | 4.53 | 366.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.7 | 359.8% | |
Avg P/E ratio | x | 33.5 | 44.1 | 75.9% | |
P/CF ratio (eoy) | x | 29.8 | 35.0 | 85.1% | |
Price / Book Value ratio | x | 10.3 | 5.4 | 190.9% | |
Dividend payout | % | 68.7 | 2.9 | 2,340.9% | |
Avg Mkt Cap | Rs m | 76,761 | 4,766 | 1,610.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 115 | 1,787.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 2,747 | 447.7% | |
Other income | Rs m | 184 | 18 | 997.3% | |
Total revenues | Rs m | 12,480 | 2,765 | 451.3% | |
Gross profit | Rs m | 3,247 | 288 | 1,126.3% | |
Depreciation | Rs m | 281 | 28 | 1,000.4% | |
Interest | Rs m | 8 | 104 | 7.4% | |
Profit before tax | Rs m | 3,142 | 175 | 1,794.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 67 | 1,264.2% | |
Profit after tax | Rs m | 2,295 | 108 | 2,123.3% | |
Gross profit margin | % | 26.4 | 10.5 | 251.6% | |
Effective tax rate | % | 27.0 | 38.3 | 70.5% | |
Net profit margin | % | 18.7 | 3.9 | 474.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 2,162 | 541.7% | |
Current liabilities | Rs m | 6,791 | 1,062 | 639.6% | |
Net working cap to sales | % | 40.0 | 40.1 | 99.9% | |
Current ratio | x | 1.7 | 2.0 | 84.7% | |
Inventory Days | Days | 263 | 3 | 8,094.7% | |
Debtors Days | Days | 343 | 459 | 74.8% | |
Net fixed assets | Rs m | 10,617 | 411 | 2,585.2% | |
Share capital | Rs m | 166 | 45 | 366.3% | |
"Free" reserves | Rs m | 7,265 | 835 | 869.8% | |
Net worth | Rs m | 7,431 | 880 | 843.9% | |
Long term debt | Rs m | 0 | 489 | 0.0% | |
Total assets | Rs m | 22,330 | 2,573 | 867.9% | |
Interest coverage | x | 409.1 | 2.7 | 15,198.7% | |
Debt to equity ratio | x | 0 | 0.6 | 0.0% | |
Sales to assets ratio | x | 0.6 | 1.1 | 51.6% | |
Return on assets | % | 10.3 | 8.2 | 125.4% | |
Return on equity | % | 30.9 | 12.3 | 251.6% | |
Return on capital | % | 42.4 | 20.3 | 208.4% | |
Exports to sales | % | 0 | 22.6 | 0.0% | |
Imports to sales | % | 13.1 | 0.2 | 6,810.1% | |
Exports (fob) | Rs m | NA | 620 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 5 | 30,463.0% | |
Fx inflow | Rs m | 1,465 | 620 | 236.2% | |
Fx outflow | Rs m | 1,605 | 5 | 30,463.0% | |
Net fx | Rs m | -140 | 615 | -22.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -144 | -1,637.9% | |
From Investments | Rs m | -215 | -94 | 228.6% | |
From Financial Activity | Rs m | -985 | 252 | -391.1% | |
Net Cashflow | Rs m | 1,160 | 14 | 8,512.8% |
Indian Promoters | % | 0.0 | 49.1 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 1.6 | 1,248.1% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 50.9 | 94.7% | |
Shareholders | 56,778 | 6,838 | 830.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES DR. REDDYS LAB
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | FREDUN PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | 0.46% | 0.35% |
1-Month | -0.62% | 15.27% | 2.45% |
1-Year | 1.28% | -4.10% | 55.99% |
3-Year CAGR | -8.59% | 26.13% | 15.18% |
5-Year CAGR | 5.08% | 13.59% | 19.61% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the FREDUN PHARMA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of FREDUN PHARMA the stake stands at 49.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of FREDUN PHARMA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
FREDUN PHARMA paid Rs 0.7, and its dividend payout ratio stood at 2.9%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of FREDUN PHARMA.
For a sector overview, read our pharmaceuticals sector report.
Asian shares rose cautiously on Friday as markets sobered up to the idea that U.S. rate cuts were most likely some time away.